Autologous haematopoietic stem-cell transplantation in multiple sclerosis: benefits and risks - PubMed (original) (raw)
Review
. 2009 Oct:30 Suppl 2:S175-7.
doi: 10.1007/s10072-009-0144-5.
Affiliations
- PMID: 19882370
- DOI: 10.1007/s10072-009-0144-5
Review
Autologous haematopoietic stem-cell transplantation in multiple sclerosis: benefits and risks
E Capello et al. Neurol Sci. 2009 Oct.
Abstract
Autologous haematopoietic stem-cell transplantation has been evaluated over the last years as a possible new therapeutic strategy in severe forms of multiple sclerosis unresponsive to the approved therapies. Up to now, more than 400 patients have been treated and numerous are the phase I and phase II studies which addressed the feasibility of this treatment, the efficacy, side effects and transplant-related mortality. The clinical response is strongly related to the intensity of the conditioning regimen utilized as well as to the phase of the disease course in which the therapy is carried out. Rapidly evolving multiple sclerosis with a relapsing-remitting clinical course and MRI signs of activity are the cases that can take more advantage. The risk of mortality, which dropped in the last years to 2-3%, is still the main problem of this powerful therapy.
Similar articles
- Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study.
Fassas A, Passweg JR, Anagnostopoulos A, Kazis A, Kozak T, Havrdova E, Carreras E, Graus F, Kashyap A, Openshaw H, Schipperus M, Deconinck E, Mancardi G, Marmont A, Hansz J, Rabusin M, Zuazu Nagore FJ, Besalduch J, Dentamaro T, Fouillard L, Hertenstein B, La Nasa G, Musso M, Papineschi F, Rowe JM, Saccardi R, Steck A, Kappos L, Gratwohl A, Tyndall A, Samijn J; Autoimmune Disease Working Party of the EBMT (European Group for Blood and Marrow Transplantation). Fassas A, et al. J Neurol. 2002 Aug;249(8):1088-97. doi: 10.1007/s00415-002-0800-7. J Neurol. 2002. PMID: 12195460 Clinical Trial. - Hematopoietic stem cell transplantation in multiple sclerosis.
Rogojan C, Frederiksen JL. Rogojan C, et al. Acta Neurol Scand. 2009 Dec;120(6):371-82. doi: 10.1111/j.1600-0404.2009.01168.x. Epub 2009 Sep 24. Acta Neurol Scand. 2009. PMID: 19785643 Review. - Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience.
Mancardi GL, Sormani MP, Di Gioia M, Vuolo L, Gualandi F, Amato MP, Capello E, Currò D, Uccelli A, Bertolotto A, Gasperini C, Lugaresi A, Merelli E, Meucci G, Motti L, Tola MR, Scarpini E, Repice AM, Massacesi L, Saccardi R; Italian BMT Study Group. Mancardi GL, et al. Mult Scler. 2012 Jun;18(6):835-42. doi: 10.1177/1352458511429320. Epub 2011 Nov 29. Mult Scler. 2012. PMID: 22127896 - Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis.
Capello E, Saccardi R, Murialdo A, Gualandi F, Pagliai F, Bacigalupo A, Marmont A, Uccelli A, Inglese M, Bruzzi P, Sormani MP, Cocco E, Meucci G, Massacesi L, Bertolotto A, Lugaresi A, Merelli E, Solari A, Filippi M, Mancardi GL; Italian GITMO-Neuro Intergroup on ASCT for Multiple Sclerosis. Capello E, et al. Neurol Sci. 2005 Dec;26 Suppl 4:S200-3. doi: 10.1007/s10072-005-0514-6. Neurol Sci. 2005. PMID: 16388358 Clinical Trial. - Autologous hemopoietic stem cell transplantation in the treatment of multiple sclerosis: rationale and clinical experience.
Fassas A, Kimiskidis VK. Fassas A, et al. J Neurol Sci. 2004 Aug 15;223(1):53-8. doi: 10.1016/j.jns.2004.04.020. J Neurol Sci. 2004. PMID: 15261561 Review.
Cited by
- Cell Therapy for Multiple Sclerosis.
Sarkar P, Rice CM, Scolding NJ. Sarkar P, et al. CNS Drugs. 2017 Jun;31(6):453-469. doi: 10.1007/s40263-017-0429-9. CNS Drugs. 2017. PMID: 28397112 Review. - Engineering Stem Cells for Biomedical Applications.
Yin PT, Han E, Lee KB. Yin PT, et al. Adv Healthc Mater. 2016 Jan 7;5(1):10-55. doi: 10.1002/adhm.201400842. Epub 2015 Mar 13. Adv Healthc Mater. 2016. PMID: 25772134 Free PMC article. Review. - Clinical trials for stem cell therapies.
Trounson A, Thakar RG, Lomax G, Gibbons D. Trounson A, et al. BMC Med. 2011 May 10;9:52. doi: 10.1186/1741-7015-9-52. BMC Med. 2011. PMID: 21569277 Free PMC article. Review. - Immune mechanisms underlying the beneficial effects of autologous hematopoietic stem cell transplantation in multiple sclerosis.
Gosselin D, Rivest S. Gosselin D, et al. Neurotherapeutics. 2011 Oct;8(4):643-9. doi: 10.1007/s13311-011-0062-0. Neurotherapeutics. 2011. PMID: 21904792 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical